Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;116(2):155-166.
doi: 10.1111/vox.13009. Epub 2020 Sep 23.

Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency

Philip Kiely  1   2 , Veronica C Hoad  1 , Clive R Seed  1 , Iain B Gosbell  1   3
Affiliations
Review

Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency

Philip Kiely et al. Vox Sang. 2021 Feb.

Abstract

Background and objective: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus, first identified in China at the end of 2019 and has now caused a worldwide pandemic. In this review, we provide an overview of the implications of SARS-CoV-2 for blood safety and sufficiency.

Material and method: We searched the PubMed database, the preprint sites bioRxiv and medRxiv, the websites of the World Health Organization, European Centre for Disease Prevention and Control, the US Communicable Diseases Center and monitored ProMed updates.

Results: An estimated 15%-46% of SARS-CoV-2 infections are asymptomatic. The reported mean incubation period is 3 to 7 days with a range of 1-14 days. The blood phase of SARS-CoV-2 appears to be brief and low level, with RNAaemia detectable in only a small proportion of patients, typically associated with more severe disease and not demonstrated to be infectious virus. An asymptomatic blood phase has not been demonstrated. Given these characteristics of SARS-CoV-2 infection and the absence of reported transfusion transmission (TT), the TT risk is currently theoretical. To mitigate any potential TT risk, but more importantly to prevent respiratory transmission in donor centres, blood centres can implement donor deferral policies based on travel, disease status or potential risk of exposure.

Conclusion: The TT risk of SARS-CoV-2 appears to be low. The biggest risk to blood services in the current COVID-19 pandemic is to maintain the sufficiency of the blood supply while minimizing respiratory transmission of SARS-CoV-19 to donors and staff while donating blood.

Keywords: SARS-CoV-2; blood safety; epidemiology; transfusion - transmissible infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

References

    1. World Health Organization : Emergencies preparedness, response. Pneumonia of unknown cause ‐ China. Disease outbreak news, 5 January 2020. https://www.who.int/csr/don/05‐january‐2020‐pneumonia‐of‐unkown‐cause‐ch... [Last accessed 25 August 2020]
    1. European Centre for Disease Prevention and Control : Cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China; – 17 January 2020. Stockholm: ECDC; 2020. https://www.ecdc.europa.eu/sites/default/files/documents/Risk%20assessme... [Last accessed Last accessed 25 August 2020]
    1. Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease: (COVID‐19) Outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–1242 - PubMed
    1. Zhou P, Yang X‐L, Wang X‐G, et al.: Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020; 2020.01.22.914952. [Epub ahead of print].
    1. Wu F, Zhao S, Yu B, et al.: A new coronavirus associated with human respiratory disease in China. Nature 2020; 579:265–269 - PMC - PubMed